Defibrillators Market Outlook
A defibrillator is a medical device that restores a normal heartbeat by delivering a controlled electric pulse or shock to the heart. A traditional defibrillator is implanted in the chest through invasive surgery with wires attaching to the heart. Currently, there are different types of defibrillators in use, including manual external, manual internal, implantable cardioverter-defibrillator (ICD), automated external defibrillator (AED), and wearable cardiac defibrillator (WCD).
The global defibrillators market reached a value of US$ 4.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.0 Billion by 2027, exhibiting a CAGR of 6.94% during 2022-2027.
These devices transfer electric current, causing depolarization, inducing impulses to the heart membrane, and stabilizing the heartbeat and its rhythm. A defibrillator reduces the risk of sudden death by terminating life-threatening disorders and tracks or monitors heart rates. As a result, it is extensively employed by healthcare practitioners to treat cardiac arrests caused due to ventricular fibrillation and arrhythmia.
Request for a Free PDF sample report: https://www.imarcgroup.com/defibrillators-market/requestsample
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Defibrillators Market Trends:
The growing prevalence of cardiovascular disorders (CVDs) and the rising incidences of sudden cardiac arrests, especially amongst the geriatric population, due to diabetes, atherosclerosis, and hypertension, are primarily driving the market growth. Moreover, significant improvements in the healthcare infrastructures and the escalating need for portable defibrillators with magnetic resonance imaging (MRI) compatibility for ease of operations are favoring the market growth.
Additionally, the ongoing development of WCDs by key players that allows the precise analysis of a person’s heart rhythm and detects and treats life-threatening ventricular tachycardia (VT), further protecting them from sudden cardiac death (SCD), is propelling the market growth. Besides this, the increasing number of home care setups in hospital settings and private organizations and the fueling focus on public access defibrillators (PAD) are contributing to the market growth.
Buy This Report Now: https://www.imarcgroup.com/checkout?id=2184&method=1
Note: In this report you will get detailed analysis of the market, growth analysis graphs, historical period analysis, forecast period analysis, major market segmentation, top leading key players of the market, table of content, list of figures, and list of tables.
Competitive Landscape with Key Players:
The report has also analysed the competitive landscape of the market with some of the key players.
- Asahi Kasei Zoll Medical Corporation
- Biotronik
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- LivaNova PLC
- Medtronic Inc.
- Nihon Kohden Corporation
- Schiller AG
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Stryker Corporation
Key Market Segmentation:
The report has categorized the market based on product type and end-user.
Breakup by Product Type:
- Implantable Defibrillators
- Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
- Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
- External Defibrillators
- Manual External Defibrillator
- Automated External Defibrillator (AEDs)
- Wearable Cardioverter Defibrillator (WCDs)
Breakup by End-User:
- Hospitals and Clinics
- Prehospital Care Settings
- Cardiac Centers
- Homecare Settings
- Others
Breakup by Region:
· North America (United States, Canada)
· Europe (Germany, France, United Kingdom, Italy, Spain, Others)
· Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
· Latin America (Brazil, Mexico, Others)
· Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2184&flag=C
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
https://www.openpr.com/news/2937371/india-laboratory-automation-market-size-companies-trends
https://www.openpr.com/news/2937375/car-sharing-market-companies-trends-share-size-growth
https://www.openpr.com/news/2937377/ready-to-eat-rte-food-market-size-target-key-players
https://www.openpr.com/news/2937484/chile-food-delivery-market-growth-value-demand-statistics
https://www.openpr.com/news/2937576/organic-and-natural-pet-food-market-trends-size-growth-factors
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800
Facebook Conversations